20.035
-4.74 (-19.12%)
-4.74 (-19.12%)
Upgrade to Real-Time
Regular Market
Low
8.39
High
26.24
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NRX Pharmaceuticals Inc | NRXP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -4.74 | -19.12% | 20.035 | 12:27:03 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 21.95 | 19.01 | 23.77 | 24.77 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 19.90 | 20.04 | 0.14 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 51,625 | 6,842,619 | $ 20.73 | $ 141,863,319 | - | 8.39 - 26.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:27:04 | 3 | $ 19.90 | USD |
Period:
Draw Mode:
NRX Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 959.97M | 47.91M | 47.82M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 32.05M | 0.20% |
NRX Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NRXP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.50 | 26.24 | 9.76 | 17.49 | 36,349,586 | 7.54 | 60.28% |
| 1 Month | 14.11 | 26.24 | 8.39 | 17.31 | 9,815,258 | 5.93 | 41.99% |
| 3 Months | 23.01 | 26.24 | 8.39 | 17.31 | 4,551,770 | -2.98 | -12.93% |
| 6 Months | 23.01 | 26.24 | 8.39 | 17.31 | 4,551,770 | -2.98 | -12.93% |
| 1 Year | 23.01 | 26.24 | 8.39 | 17.31 | 4,551,770 | -2.98 | -12.93% |
| 3 Years | 23.01 | 26.24 | 8.39 | 17.31 | 4,551,770 | -2.98 | -12.93% |
| 5 Years | 23.01 | 26.24 | 8.39 | 17.31 | 4,551,770 | -2.98 | -12.93% |
NRX Pharmaceuticals Description
| NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior. |
